June 11, 2024
For Immediate Release: June 11, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
June 11, 2024
From a public health perspective, early identification of important adverse events is beneficial. For example, a relatively rare adverse event might be detected during expanded access […]
June 11, 2024
The US Food and Drug Administration (FDA) has approved sarilumab (Kevzara) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) for patients weighing ≥ 63 kg […]
June 11, 2024
A new broadly inclusive definition of long COVID from the National Academies of Sciences, Engineering, and Medicine (NASEM) has been developed with the aim of improving […]
June 11, 2024
The US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic […]
June 11, 2024
Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Mr. John Puckett Recipient Title President and COO Cosmetic Solutions, LLC 6101 Park of Commerce Blvd.Boca […]
June 11, 2024
Delivery Method: VIA EMAIL WITH READ RECEIPT Product: Drugs Recipient: Recipient Name Mr. Nurshakinah Mohd TCT Nutraceuticals SDN. BHD No. 13 Jalan PP11/3Taman Putra Perdana47130 PuchongSelangorMalaysia […]
June 11, 2024
Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Pedro Branco Recipient Title Chief Executive Officer Fancystage Unipessoal, LDA Rua da Cumieira 31Santiago Do Bougado […]
June 11, 2024
Delivery Method: Via Email Product: Animal & VeterinaryDrugs Recipient: Recipient Name Yvette Pittman Recipient Title CEO Toltrazuril Shop 4960 HWY 90, Suite 214Pace, FL 32571United States […]